Synthesis and evaluation of 1- and 2-substituted fentanyl analogs for opioid activity

Journal of Medicinal Chemistry
1983.0

Abstract

We synthesized fentanyl analogues that possess key groups common to the opioid peptides to investigate whether or not these two classes of compounds interact with common subsites on opioid receptors. The design of the analogues was based on the possibility of structural analogy between the two aromatic rings of fentanyl and the Tyr1 and Phe4 residues of the opioid peptides. The synthesized compounds showed very weak or no opioid activity as tested in the electrically stimulated longitudinal muscle of the guinea pig ileum or mouse vas deferens preparations. These results, together with those of reported studies, suggest that fentanyl and the opioid peptides interact with different subsites on either mu or sigma receptors. Studies using the irreversible mu opioid receptor antagonist, beta-funaltrexamine, indicate that fentanyl interacts preferentially with mu opioid receptors.

Knowledge Graph

Similar Paper

Synthesis and evaluation of 1- and 2-substituted fentanyl analogs for opioid activity
Journal of Medicinal Chemistry 1983.0
“Carba”-Analogues of Fentanyl are Opioid Receptor Agonists<sup>‡</sup>‡ Dedicated to the memory of Ralph F. Hirschmann.
Journal of Medicinal Chemistry 2010.0
Design and synthesis of naltrexone-derived affinity labels with nonequilibrium opioid agonist and antagonist activities. Evidence for the existence of different .mu. receptor subtypes in different tissues
Journal of Medicinal Chemistry 1984.0
β-Fluorofentanyls Are pH-Sensitive Mu Opioid Receptor Agonists
ACS Medicinal Chemistry Letters 2019.0
Synthesis and activity profiles of new dermorphin-(1-4) peptide analogs
Journal of Medicinal Chemistry 1987.0
Synthesis and biological activity of analogs of .beta.-chlornaltrexamine and .beta.-funaltrexamine at opioid receptors
Journal of Medicinal Chemistry 1986.0
Allylprodine analogs as receptor probes. Evidence that phenolic and nonphenolic ligands interact with different subsites on identical opioid receptors
Journal of Medicinal Chemistry 1981.0
New 4-(heteroanilido)piperidines, structurally related to the pure opioidagonist fentanyl, with agonist and/or antagonist properties
Journal of Medicinal Chemistry 1989.0
Cyclic .beta.-Casomorphin Analogs with Mixed .mu. Agonist/.delta. Antagonist Properties: Synthesis, Pharmacological Characterization, and Conformational Aspects
Journal of Medicinal Chemistry 1994.0
Minimum-structure enkephalin analogs incorporating L-tyrosine, D (or L)-phenylalanine, and a diamine spacer
Journal of Medicinal Chemistry 1989.0